Investors
We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Parnell Pharmaceuticals Holdings’s financial performance into perspective.
Press Releases
May 31, 2023
Parnell Adds Three Experts to Leadership Team
May 31, 2023
Two New Territory Business Managers Help Parnell Better Serve Producers and Veterinarians
Mar 7, 2023
Parnell Pharmaceuticals Gives Notice of Annual General Meeting and Explanatory Memorandum
Jan 25, 2023
Parnell Living Science Introduces BRD Solution RESPIRmycin™
Jan 6, 2023
Parnell Pharmaceuticals Holdings Ltd Announces Extension of Rights Offering
Events & Presentations
May 30, 2017 at 4:00 PM CT
Parnell Pharmaceuticals Holdings Ltd Annual General Meeting
May 24, 2017 at 5:00 PM ET
Parnell Pharmaceuticals Holding Ltd Business Update
Investors and analysts may access the conference call by dialing (877) 244-6184 (U.S./Canada) or (920) 663-6271 (International) and using the conference ID# 27440696